Cite
Shaikh F, Chan AC, Awan O, et al. Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma. Cureus. 2015;7(9):e319doi: 10.7759/cureus.319.
Shaikh, F., Chan, A. C., Awan, O., Jerath, N., Reddy, C., Khan, S. A., & Graham, M. M. (2015). Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma. Cureus, 7(9), e319. https://doi.org/10.7759/cureus.319
Shaikh, Faiq, et al. "Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma." Cureus vol. 7,9 (2015): e319. doi: https://doi.org/10.7759/cureus.319
Shaikh F, Chan AC, Awan O, Jerath N, Reddy C, Khan SA, Graham MM. Diagnostic Yield of FDG-PET/CT, MRI, and CSF Cytology in Non-Biopsiable Neurolymphomatosis as a Heralding Sign of Recurrent Non-Hodgkin's Lymphoma. Cureus. 2015 Sep 09;7(9):e319. doi: 10.7759/cureus.319. PMID: 26487995; PMCID: PMC4601979.
Copy
Download .nbib